NEW YORK--(BUSINESS WIRE)--Tyme Technologies, Inc. (Tyme, Inc.) (OTC QB:TYMI), a cancer research company focused on developing and commercializing products in the oncology space, announced the appointment of Mario Eisenberger, MD to its Medical Advisory Board. Dr. Eisenberger is renowned with more than 30 years of oncology experience and, as a member the Tyme, Inc.
Help employers find you! Check out all the jobs and post your resume.
